Drug Database
Back to search

Poland· PL-100248725

Oslif Breezhaler

A indacaterol product containing indacaterolum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 13 of our 19 countries.

ATC R03AC18

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedOslif BreezhalerATCR03AC18REGISTER NO.PL-100248725PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about indacaterolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Indacaterol is registered in 13 of 19 countries.

Countries holding a registration under ATC R03AC18 (indacaterol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search indacaterol products by name

Indacaterol · ATC R03AC18

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of indacaterol costs, country by country.

Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Indacaterol · price per daily dose (0.15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Indacaterolum
Manufacturer
Novartis Europharm Limited
Country
Poland (PL)
ATC code
R03AC18
ATC class
Indacaterol
Defined daily dose
0.15 mg, Inhal
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909990869084
  • gtin
    05909990869091
  • gtin
    05909990869107
  • gtin
    05909990869145
  • gtin
    05909990869152

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

529 interactions on record for indacaterol.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check indacaterol against other medicinesHow interaction checks work

Indacaterol · interactions on record

529 records

  • 20 severe
  • 408 moderate
  • 101 minor

Most severe, free to view

  • PindololC07AA03severe
  • PropranololC07AA05severe
  • TimololC07AA06severe
  • SotalolC07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Indacaterol in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All indacaterol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Hirobriz Breezhaler, Onbrez Breezhaler
  • Liechtenstein · Hirobriz Breezhaler, Onbrez Breezhaler
  • Norway · Hirobriz Breezhaler, Onbrez Breezhaler

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac5643a0-4592-4b6e-abf3-0420c78f0b8c
GET /v1/drugs/ac5643a0-4592-4b6e-abf3-0420c78f0b8c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do inhalacji w kapsułkach twardych",
  "source": "urpl",
  "strength": "150 mcg",
  "packaging": "05909990869084 ¦ Rp ¦ EU/1/09/586/001 ¦ 66578\n10 kaps. ¦ 1 inhalator \n05909990869091 ¦ Rp ¦ EU/1/09/586/002 ¦ 66579\n30 kaps. ¦ 1 inhalator \n05909990869107 ¦ Rp ¦ EU/1/09/586/003 ¦ 66580\n60 kaps. ¦ 2 inhalatory \n05909990869145 ¦ Rp ¦ EU/1/09/586/004 ¦ 66581\n90 kaps. ¦ 3 inhalatory \n05909990869152 ¦ Rp ¦ EU/1/09/586/005 ¦ 66582\n300 kaps. ¦ 10 inhalatorów",
  "substance": "Indacateroli maleas 150 mcg",
  "common_name": "Indacaterolum",
  "pl_product_id": "100248725",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about indacaterol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console